AI Insight
Researchers at Mayo Clinic have identified synthetic DNA molecules called aptamers that can selectively bind to senescent cells, commonly referred to as zombie cells due to their dysfunctional, non-dividing state. These senescent cells accumulate with age and are associated with conditions including cancer and neurodegenerative diseases. The discovery provides a more precise molecular tool for detecting and potentially targeting these cells in living tissue.
Why it matters
If developed further, aptamer-based targeting could enable more accurate diagnostics and therapeutic interventions for age-related diseases, reducing the collateral damage associated with less selective approaches. This may represent a meaningful step toward senolytic therapies designed to selectively clear harmful senescent cells from the body.
A casual conversation between graduate students helped spark a breakthrough in aging research at Mayo Clinic. Researchers discovered that tiny synthetic DNA molecules called aptamers can selectively attach to senescent “zombie cells,” which are linked to aging, cancer, and neurodegenerative disease. The method could eventually help scientists identify and target these cells in living tissue with far greater precision.
Source: A grad student’s wild idea sparks a major aging breakthrough